Company:  NATERA, INC. (NTRA)
Form Type:  4
Filing Date:  11/19/2019 
CIK:  0001604821 
Address:  201 INDUSTRIAL ROAD
SUITE 410
 
City, State, Zip:  SAN CARLOS, California 94070 
Telephone:  650-249-9090 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$36.72  
Change: 
0.56 (1.55%)  
Trade Time: 
Dec 06  
Market Cap: 
$2.85B
Trade NTRA now with 

© 2019  
Description of Business
We are a growing diagnostics company with proprietary molecular and bioinformatics technology that we are deploying to change the management of disease worldwide. Our novel molecular assays reliably measure many informative regions across the genome from samples as small as a single cell. Our statistical algorithms combine these measurements with data available from the broader scientific community to identify genetic variations covering a wide range of serious conditions with best-in-class accuracy and coverage. Our goal is to develop and commercialize non- or minimally- invasive tests to evaluate risk, and thereby enable early detection, for a wide range of genetic conditions, such as Down syndrome, as well as cancer and organ transplant rejection. Our technology has been proven clinically and commercially in the prenatal testing space.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES